Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
SUPN
SUPN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SUPN News
Supernus Pharmaceuticals Reports Q4 2025 Results and 2026 Guidance
Feb 25 2026
NASDAQ.COM
Supernus Pharmaceuticals Reports Record Q4 2025 Earnings and Strategic Progress
Feb 25 2026
seekingalpha
Supernus Pharmaceuticals Reports Strong Q4 2025 Earnings and Revenue Growth
Feb 25 2026
NASDAQ.COM
Supernus Pharmaceuticals Q4 2025 Earnings Exceed Expectations
Feb 24 2026
seekingalpha
Supernus Pharmaceuticals to Participate in Investor Conferences
Feb 23 2026
Newsfilter
Supernus Pharmaceuticals Q4 Earnings Announcement Scheduled
Feb 23 2026
seekingalpha
Strategic Shift in Biotech Dealmaking
Feb 17 2026
Globenewswire
Strategic Shift in Biopharma Dealmaking
Feb 17 2026
Newsfilter
Supernus Pharmaceuticals to Report Q4 and Full Year 2025 Results
Feb 12 2026
Newsfilter
Lunai Bioworks Launches AI Drug Discovery Platform
Feb 09 2026
PRnewswire
Lunai Bioworks Launches AI Drug Discovery Platform
Feb 09 2026
Newsfilter
Supernus Shares Rise 31% Over the Past Year, Yet Remain 20% Lower Than 2018 Peaks Amid Fund Reduction
Dec 16 2025
NASDAQ.COM
Bank of America Identifies Five Stocks with Strong Growth Potential for 2025
Dec 01 2025
TipRanks
Evaluating Supernus Pharmaceuticals Following FDA Pipeline Update and 24% Surge in 2025
Nov 24 2025
Yahoo Finance
Biotech Stocks Reach 52-Week Peaks: MTSR, INSM, ABVX, and MAZE Drive Surge on October 30
Oct 31 2025
NASDAQ.COM
Key Analyst Recommendations for Wednesday: Nvidia, Apple, Tesla, Victoria's Secret, Wayfair, Palantir, Datadog, and Others
Oct 29 2025
CNBC
Show More News
